Clinical Trial Update: Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating high-dose oral corticosteroids for treating relapses in multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED